EA199800533A1 - Композиция для лечения боли - Google Patents

Композиция для лечения боли

Info

Publication number
EA199800533A1
EA199800533A1 EA199800533A EA199800533A EA199800533A1 EA 199800533 A1 EA199800533 A1 EA 199800533A1 EA 199800533 A EA199800533 A EA 199800533A EA 199800533 A EA199800533 A EA 199800533A EA 199800533 A1 EA199800533 A1 EA 199800533A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
pain
treatment
compounds
opioids
Prior art date
Application number
EA199800533A
Other languages
English (en)
Russian (ru)
Inventor
Чарлз Х. Митч
Харлан Э. Шэннон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800533A1 publication Critical patent/EA199800533A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EA199800533A 1995-12-07 1996-12-05 Композиция для лечения боли EA199800533A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US829995P 1995-12-07 1995-12-07
PCT/US1996/019309 WO1997020561A1 (en) 1995-12-07 1996-12-05 Composition for treating pain

Publications (1)

Publication Number Publication Date
EA199800533A1 true EA199800533A1 (ru) 1999-02-25

Family

ID=21730869

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800533A EA199800533A1 (ru) 1995-12-07 1996-12-05 Композиция для лечения боли

Country Status (13)

Country Link
EP (1) EP0871445A4 (cs)
JP (1) JP2000501709A (cs)
KR (1) KR19990071976A (cs)
CN (1) CN1208349A (cs)
AU (1) AU705031B2 (cs)
CA (1) CA2238815A1 (cs)
CZ (1) CZ174698A3 (cs)
EA (1) EA199800533A1 (cs)
IL (1) IL124419A0 (cs)
NO (1) NO982562L (cs)
NZ (1) NZ324988A (cs)
PL (1) PL327137A1 (cs)
WO (1) WO1997020561A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1007041A4 (en) * 1997-04-11 2001-03-07 Lilly Co Eli COMPOSITION FOR TREATING PAIN
ATE248166T1 (de) 1999-06-04 2003-09-15 Lilly Co Eli 7-oxo-2-azabicyclo(2.2.1)heptane als selektive muskarin-rezeptor antagonisten
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US12396988B2 (en) * 2019-04-04 2025-08-26 Board Of Regents, The University Of Texas System Methods of using muscarinic antagonists in the treatment of depression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) * 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5260293A (en) * 1988-01-30 1993-11-09 Merck Sharp & Dohme Limited Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
IL89351A0 (en) * 1988-03-14 1989-09-10 Lundbeck & Co As H 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
CA2185805A1 (en) * 1994-03-18 1995-09-28 Georg Frank Low dosage ketoprofen

Also Published As

Publication number Publication date
EP0871445A4 (en) 2001-01-10
KR19990071976A (ko) 1999-09-27
CZ174698A3 (cs) 1998-10-14
NO982562L (no) 1998-07-10
JP2000501709A (ja) 2000-02-15
NZ324988A (en) 1999-08-30
WO1997020561A1 (en) 1997-06-12
AU705031B2 (en) 1999-05-13
PL327137A1 (en) 1998-11-23
CA2238815A1 (en) 1997-06-12
NO982562D0 (no) 1998-06-04
EP0871445A1 (en) 1998-10-21
IL124419A0 (en) 1998-12-06
CN1208349A (zh) 1999-02-17
AU1279197A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
DE69626864D1 (de) Abwasserbecken ZUR AEROBEN BEHANDLUNG VON ABWASSER beinhaltend Träger
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
EP0709090A3 (en) Compositions for the treatment of resistant tumors
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK0946166T3 (da) Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
DE69423131D1 (de) Verfahren zur Behandlung von Mycobakterien enthaltenden Auswürfen
ATE267187T1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
EA199800533A1 (ru) Композиция для лечения боли
HUP9700598A2 (hu) Eljárás hasnyálmirigy-gyulladás megelőzésére és kezelésére alkalmas gyógyszerkészítmény előállítására
DE69737067D1 (de) Vakzine zur behandlung von mycosen
PT1024809E (pt) Utilizacao de agentes de imunomodulacao
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
EA199800535A1 (ru) Способ лечения боли
DE69706758D1 (de) Verfahren zur Behandlung von Polyolefin
NO20005548L (no) Mykobakterieinhibitorer
HUP9701618A2 (hu) Tramadolt és valamely kálciumcsatorna antagonistát tartalmazó gyógyászati készítmény
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
BR9703403B1 (pt) compostos, processo para preparação de compostos, utilização de composto e processo para preparação de composição farmacêutica.
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.